New Cost-Saving Inhaler Added to Hampshire & Isle of Wight ICB Respiratory Formulary

 

HIOW ICB has updated its respiratory inhaler choices, adding Proxor—a new branded inhaler—as a preferred option.

Proxor® is therapeutically equivalent to Fostair® pressurised metered dose inhaler (pMDI) for formulation and device characteristics and does not contain maleic acid as seen in other branded generics.

Proxor® is available to order in the UK priced at £9.90

For full prescribing details, visit: 

Proxor 100/6 microgram per actuation pressurised inhalation solution - Summary of Product Characteristics (SmPC) - (emc) | 100548

Proxor 200/6 micrograms per actuation pressurised inhalation solution - Summary of Product Characteristics (SmPC) - (emc) | 100549

Please see below the link to both the patient website for our respiratory products and the website for HCPs.

• www.stadarespiratory.co.uk for HCPs
• www.proxor.co.uk For Patients

 

 

QR Code - link to patient resources

Formulary and Implementation Support

Proxor can provide patient support materials and demonstration devices. 

If you would like any placebo devices, hard copies of the MART Action plans or patient information leaflets, or have any questions, please contact your local  representative Sonya Brown at Sonyabrown@thorntonross.com